NRX Pharmaceuticals Financial Overview
NRX Pharmaceuticals's market cap is currently $58.16M. The company's EPS TTM is $-0.27; its P/E ratio is -0.84; NRX Pharmaceuticals is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
